Purchases and Sales Made in Q2 2022 in Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY) during Q2 2022. The information is specifically focused on institutions that hold shares of Inozyme Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2022
Q2 2022
|
Corton Capital Inc.
Carrying Place, A6 |
SELL
|
- |
-11.4KClosed |
$36.3K - $67.6K
|
0
$0
|
|
|
Aug 10, 2022
Q2 2022
|
Citigroup Inc
|
SELL
|
- |
-12.4K- 98.86% |
$39.6K - $73.7K
|
143
$420
|
|
|
Aug 11, 2022
Q2 2022
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-12.9KClosed |
$41.2K - $76.8K
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-13.9K- 45.74% |
$44.6K - $83.1K
|
16.5K
$48.7K
|
|
|
Aug 15, 2022
Q2 2022
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-18.1K- 45.27% |
$58K - $108K
|
21.9K
$64.4K
|
|
|
Aug 15, 2022
Q2 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-43.6KClosed |
$139K - $260K
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-66.8K- 58.72% |
$214K - $398K
|
47K
$138K
|
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-140K- 74.05% |
$448K - $834K
|
49.1K
$144K
|
|
|
Aug 11, 2022
Q2 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-311K- 99.98% |
$995K - $1.85M
|
60
$176
|
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-351K- 96.56% |
$1.12M - $2.09M
|
12.5K
$36.8K
|
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-448K- 50.99% |
$1.43M - $2.67M
|
431K
$1.27M
|
|
|
Aug 15, 2022
Q2 2022
|
Suvretta Capital Management, LLC
New York, NY |
SELL
|
- |
-1.01MClosed |
$3.24M - $6.04M
|
0
$0
|